Search
Patexia Research
Case number 1:20-cv-01256

Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. > Documents

Date Field Doc. No.Description (Pages)
May 21, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [106] Stipulation of Dismissal filed by Bionpharma Inc., ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/19/21. (ntl)
May 21, 2021 107 Patent/Trademark Report to Commissioner (5)
Docket Text: Report to the Commissioner of Patents and Trademarks. (ntl)
May 17, 2021 106 Stipulation of Dismissal (4)
Docket Text: STIPULATION of Dismissal (Joint) by Bionpharma Inc.. (Phillips, John)
May 14, 2021 97 Redacted Document (27)
Docket Text: REDACTED VERSION of (68 in 1:20-cv-01256-LPS) Opening Brief in Support, (219 in 1:19-cv-01067-LPS) Opening Brief in Support, (232 in 1:18-cv-01962-LPS) Opening Brief in Support, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1-8, # (2) Appendix A-B)(Dellinger, Megan)
May 14, 2021 97 Exhibit 1-8 (78)
May 14, 2021 97 Appendix A-B (5)
May 14, 2021 98 Redacted Document (2)
Docket Text: REDACTED VERSION of (220 in 1:19-cv-01067-LPS, 69 in 1:20-cv-01256-LPS, 233 in 1:18-cv-01962-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1-3)(Dellinger, Megan)
May 14, 2021 98 Exhibit 1-3 (6)
May 14, 2021 99 Redacted Document (2)
Docket Text: REDACTED VERSION of (234 in 1:18-cv-01962-LPS, 70 in 1:20-cv-01256-LPS, 221 in 1:19-cv-01067-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1-21)(Dellinger, Megan)
May 14, 2021 99 Exhibit 1-21 (76)
May 14, 2021 100 Redacted Document (2)
Docket Text: REDACTED VERSION of (71 in 1:20-cv-01256-LPS, 222 in 1:19-cv-01067-LPS, 235 in 1:18-cv-01962-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-M)(Dellinger, Megan)
May 14, 2021 100 Exhibit A-M (137)
May 14, 2021 101 Redacted Document (22)
Docket Text: REDACTED VERSION of (240 in 1:19-cv-01067-LPS) Reply Brief, (84 in 1:20-cv-01256-LPS) Reply Brief, (253 in 1:18-cv-01962-LPS) Reply Brief by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 9-12)(Dellinger, Megan)
May 14, 2021 101 Exhibit 9-12 (55)
May 14, 2021 102 Redacted Document (2)
Docket Text: REDACTED VERSION of (254 in 1:18-cv-01962-LPS, 85 in 1:20-cv-01256-LPS, 241 in 1:19-cv-01067-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit N-U)(Dellinger, Megan)
May 14, 2021 102 Exhibit N-U (193)
May 14, 2021 103 Redacted Document (2)
Docket Text: REDACTED VERSION of (255 in 1:18-cv-01962-LPS, 242 in 1:19-cv-01067-LPS, 86 in 1:20-cv-01256-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 22-39)(Dellinger, Megan)
May 14, 2021 103 Exhibit 22-39 (70)
May 14, 2021 104 Redacted Document (2)
Docket Text: REDACTED VERSION of (243 in 1:19-cv-01067-LPS, 87 in 1:20-cv-01256-LPS, 256 in 1:18-cv-01962-LPS) Declaration, by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 4-6)(Dellinger, Megan)
May 14, 2021 104 Exhibit 4-6 (6)
May 14, 2021 105 Redacted Document (29)
Docket Text: REDACTED VERSION of (234 in 1:19-cv-01067-LPS, 79 in 1:20-cv-01256-LPS, 247 in 1:18-cv-01962-LPS) Declaration, (77 in 1:20-cv-01256-LPS) Answering Brief in Opposition, (232 in 1:19-cv-01067-LPS) Answering Brief in Opposition, (245 in 1:18-cv-01962-LPS) Answering Brief in Opposition to Plaintiff Silvergate's Preliminary Injunction Motion by Bionpharma Inc.. (Attachments: # (1) Exhibit A & B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E - K)(Haney, Megan)
May 14, 2021 105 Exhibit A & B (3)
May 14, 2021 105 Exhibit C (1371)
May 14, 2021 105 Exhibit D (1342)
May 14, 2021 105 Exhibit E - K (253)
May 13, 2021 96 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by Megan C. Haney on behalf of Bionpharma Inc. (Haney, Megan)
May 11, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [94] STIPULATION TO EXTEND TIME for Silvergate Pharmaceuticals, Inc. to File its Reply Letter in Support of its Motion for Leave to File Third Amended Complaint to May 24, 2021 filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 5/10/21. (ntl)
May 11, 2021 95 Notice of Substitution of Counsel (1)
Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Bionpharma Inc.: Entry of appearance of attorney John C. Phillips, Jr. Attorney Kenneth L. Dorsney terminated. (Phillips, John)
May 10, 2021 94 Stipulation to EXTEND Time (1)
Docket Text: STIPULATION TO EXTEND TIME for Silvergate Pharmaceuticals, Inc. to File its Reply Letter in Support of its Motion for Leave to File Third Amended Complaint to May 24, 2021 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
May 5, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [93] STIPULATION AND [PROPOSED] ORDER REGARDINGEXTENDING DEADLINES filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 5/5/21. (ntl)
May 3, 2021 93 Stipulation (2)
Docket Text: STIPULATION to Amend Scheduling Order by Bionpharma Inc.. (Hitch, Cortlan)
Apr 28, 2021 N/A Order Cancelling Deadline (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the preliminary injunction hearing scheduled for April 29, 2021 is CANCELLED. ORDERED by Judge Leonard P. Stark on 4/28/21. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Apr 27, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Matthew R. Reed for Silvergate Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (myr)
Apr 27, 2021 88 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding upcoming preliminary injunction hearing. (Dellinger, Megan)
Apr 27, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' letter (D.I. 245), and in view of the fact that the Court earlier today issued its opinion and order on the issues that were the subject of the February trial, IT IS HEREBY ORDERED that: (i) the preliminary injunction hearing on Thursday, to the extent still required, will be held by teleconference; (ii) the parties shall submit to the Court call-in information for the Court and for the public, the latter of which the Court will place on the docket; and (iii) the parties should provide their updated positions on the necessary length of the hearing in their submissions already-ordered for tomorrow. ORDERED by Judge Leonard P. Stark on 4/27/21. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Apr 27, 2021 90 Notice (Other) (2)
Docket Text: NOTICE of Withdrawal of Motion by Silvergate Pharmaceuticals, Inc. re (218 in 1:19-cv-01067-LPS, 231 in 1:18-cv-01962-LPS, 67 in 1:20-cv-01256-LPS) MOTION for Preliminary Injunction (Dellinger, Megan)
Apr 27, 2021 91 Letter (2)
Docket Text: Joint Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Preliminary Injunction Motion - re (246 in 1:19-cv-01067-LPS, 259 in 1:18-cv-01962-LPS) Order, (89 in 1:20-cv-01256-LPS, 260 in 1:18-cv-01962-LPS, 247 in 1:19-cv-01067-LPS) Order,,,. (Dellinger, Megan)
Apr 23, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (53 in 1:20-cv-01255-LPS, 81 in 1:20-cv-01256-LPS) STIPULATION and [Proposed] Order to Defer Briefing on Issues Relating to Indefiniteness and Regarding Claim Construction Briefing filed by Amneal Pharmaceuticals LLC. Signed by Judge Leonard P. Stark on 4/22/21. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Apr 23, 2021 83 Letter (5)
Docket Text: Letter to The Honorable Leonard P. Stark from Kenneth L. Dorsney regarding Bionpharma's Opposition to Plaintiff's Motion for Leave to File Third Amended Complaint - re [63] Letter, [62] MOTION for Leave to File Third Amended Complaint. (Dorsney, Kenneth)
Apr 21, 2021 80 Motion for Miscellaneous Relief (6)
Docket Text: MOTION for an Extension of Pages for Its Reply Brief in Support of Its Motion for Preliminary Injunction or, in the Alternative, to Strike Certain Portions of Bionpharma's Answering Brief (Expedited Request) - filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1)(Dellinger, Megan)
Apr 21, 2021 80 Exhibit 1 (6)
Apr 21, 2021 81 Stipulation (4)
Docket Text: STIPULATION and [Proposed] Order to Defer Briefing on Issues Relating to Indefiniteness and Regarding Claim Construction Briefing by Amneal Pharmaceuticals LLC.. (Wilson, Samantha)
Apr 21, 2021 82 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Opening Claim Construction Brief filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Apr 19, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (244 in 1:18-cv-01962-LPS, 231 in 1:19-cv-01067-LPS, 76 in 1:20-cv-01256-LPS) MOTION for Pro Hac Vice Appearance of Attorney Matthew R. Reed filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/19/21. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Apr 15, 2021 76 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew R. Reed - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Apr 8, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [65] STIPULATION TO EXTEND TIME for letter briefing on Silvergate's Motion for Leave to File Third Amended Complaint to April 23, 2021 for Bionpharma's Responsive Letter and May 10, 2021 for Silvergate's Reply Letter filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 4/7/21. (ntl)
Apr 7, 2021 75 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for Silvergate Pharmaceuticals, Inc. and Bionpharma Inc. to File Redacted Versions of Preliminary Injunction Briefing to May 14, 2021 - filed by Bionpharma Inc.. (Hitch, Cortlan)
Apr 6, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (66 in 1:20-cv-01256-LPS, 51 in 1:20-cv-01255-LPS) STIPULATION TO EXTEND TIME for the parties to submit the Joint Claim Construction Chart to April 5, 2021 filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 4/5/21. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Apr 5, 2021 74 Claim Construction Chart (3)
Docket Text: CLAIM Construction Chart by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-C)(Dellinger, Megan)
Apr 5, 2021 74 Exhibits A-C (748)
Apr 2, 2021 73 Answer to Counterclaim (19)
Docket Text: ANSWER to [57] Answer to Amended Complaint, Counterclaim by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Mar 31, 2021 66 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit the Joint Claim Construction Chart to April 5, 2021 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 31, 2021 67 Motion for Preliminary Injunction (3)
Docket Text: MOTION for Preliminary Injunction - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 31, 2021 72 Notice (Other) (2)
Docket Text: NOTICE of Lodging by Silvergate Pharmaceuticals, Inc. re (234 in 1:18-cv-01962-LPS, 70 in 1:20-cv-01256-LPS, 221 in 1:19-cv-01067-LPS) Declaration, (Dellinger, Megan)
Mar 30, 2021 65 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for letter briefing on Silvergate's Motion for Leave to File Third Amended Complaint to April 23, 2021 for Bionpharma's Responsive Letter and May 10, 2021 for Silvergate's Reply Letter - filed by Bionpharma Inc.. (Dorsney, Kenneth)
Mar 24, 2021 62 Motion for Leave to File (4)
Docket Text: MOTION for Leave to File Third Amended Complaint - filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit A-C, # (3) Exhibit 2)(Dellinger, Megan)
Mar 24, 2021 62 Exhibit 1 (12)
Mar 24, 2021 62 Exhibit A-C (86)
Mar 24, 2021 62 Exhibit 2 (13)
Mar 24, 2021 63 Letter (4)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan Dellinger regarding opening letter brief in support of Plaintiff's Motion for Leave to File a Third Amended Complaint - re [62] MOTION for Leave to File Third Amended Complaint. (Dellinger, Megan)
Mar 24, 2021 64 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Bionpharma's Disclosure of Invalidity Defenses filed by Bionpharma Inc..(Dorsney, Kenneth)
Mar 22, 2021 61 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Plaintiff's Identification of Claims on Which It May Move for a Preliminary Injunction filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Mar 18, 2021 60 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Disclosure of Proposed Claim Terms and Constructions for U.S. Patent Nos. 10,772,868, 10,786,482, and 10,918,621 B2 filed by Amneal Pharmaceuticals LLC., Bionpharma Inc..(Wilson, Samantha)
Mar 17, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' letters (C.A. No. 18-1962 D.I. 207, 212, 213), and considering the representations made by both parties in them, IT IS HEREBY ORDERED that: (1) the Court is not ordering Bionpharma to provide notice of launch; (2) on March 22, Silvergate shall disclose to Bionpharma no more than 12 claims on which it may move for a preliminary injunction; (3) on March 24, Bionpharma shall disclose all bases on which it may seek to invalidate any of those 12 claims including by disclosing any prior art references it may use in connection with its invalidity positions; (4) Silvergate's motion for a preliminary injunction and opening brief is due no later than March 31; (5) Bionpharma's answering brief is due no later than April 19; (6) Silvergate's reply brief is due no later than April 26; and (7) the Court will hold a remote preliminary injunction hearing, if necessary, on April 29 at 1:30 p.m. The Court believes this schedule is fair and reasonable to both sides and to the Court. ORDERED by Judge Leonard P. Stark on 3/17/21. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Mar 17, 2021 59 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Plaintiff's Disclosure of Proposed Claim Terms and Constructions for U.S. Patent Nos. 10,772,868, 10,786,482, and 10,918,621 filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Mar 12, 2021 57 Answer to Amended Complaint (30)
Docket Text: ANSWER to Amended Complaint, re: [49] Amended Complaint Answer to Second Amended Compliant, COUNTERCLAIM against All Plaintiffs by Bionpharma Inc..(Dorsney, Kenneth)
Mar 11, 2021 54 Redacted Document (2)
Docket Text: REDACTED VERSION of (213 in 1:18-cv-01962-LPS, 53 in 1:20-cv-01256-LPS, 200 in 1:19-cv-01067-LPS) Letter, by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 11, 2021 55 Redacted Document (2)
Docket Text: REDACTED VERSION of (207 in 1:18-cv-01962-LPS, 51 in 1:20-cv-01256-LPS, 194 in 1:19-cv-01067-LPS) Letter by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Mar 11, 2021 56 Redacted Document (18)
Docket Text: REDACTED VERSION of (199 in 1:19-cv-01067-LPS, 52 in 1:20-cv-01256-LPS, 212 in 1:18-cv-01962-LPS) Letter by Bionpharma Inc.. (Dorsney, Kenneth)
Mar 9, 2021 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Corrected letter added to D.I. 212 in 18-1962, D.I. 199 in 19-1067, and D.I. 52 in 20-1256 per request of counsel. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Mar 4, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [48] STIPULATION and [Proposed] Order to File Second Amended Complaint filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 3/4/21. (ntl)
Mar 4, 2021 49 Amended Complaint (10)
Docket Text: Second AMENDED COMPLAINT for Patent Infringement against Bionpharma Inc.- filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-C)(Dellinger, Megan)
Mar 4, 2021 49 Exhibit A-C (86)
Mar 4, 2021 50 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,772,868 ;10,786,482 ;10,918,621 . (Dellinger, Megan)
Mar 4, 2021 49 Amended Complaint* (1)
Mar 3, 2021 48 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order to File Second Amended Complaint by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits 1-2)(Dellinger, Megan)
Mar 3, 2021 48 Exhibits 1-2 (109)
Jan 27, 2021 47 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Initial Disclosures Pursuant to Rule 26(a)(1) filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 25, 2021 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
Jan 25, 2021 45 Notice of Service (2)
Docket Text: NOTICE OF SERVICE of Bionpharma's Rule 26(a)(1) Initial Disclosures filed by Bionpharma Inc..(Dorsney, Kenneth)
Jan 25, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER: If during the history of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Burke, they should contact chambers by e-mail at Deborah_Benyo@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Burke regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. Ordered by Judge Christopher J. Burke on 1/25/2021. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS(dlb)
Jan 22, 2021 43 Scheduling Order (18)
Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 7/31/2021. Status Report due by 5/31/2021. Joint Claim Construction Brief due by 6/6/2021. A Markman Hearing is set for 7/14/2021 at 04:00 PM before Judge Leonard P. Stark. Proposed Pretrial Order due by 1/14/2022. A Final Pretrial Conference is set for 1/21/2022 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 4-day Bench Trial is set for 2/1/2022 at 08:30 PM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 1/22/21. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Jan 22, 2021 N/A Order (0)
Docket Text: ORAL ORDER: Having reviewed the parties' proposed scheduling order with embedded disputes and cover letter (dated December 29, 2020), IT IS HEREBY ORDERED that Plaintiff's proposed schedule is more reasonable and appropriate, particularly with respect to a February 2022 trial date. The Court has adopted and entered a schedule consistent with this finding. ORDERED by Judge Leonard P. Stark on 1/22/21. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Jan 6, 2021 41 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 6, 2021 42 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Identification of Accused Products and Asserted Patents Pursuant to Paragraph 4.a of the Delaware Default Standard for Discovery filed by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 4, 2021 39 Answer to Counterclaim (20)
Docket Text: ANSWER to [32] Answer to Amended Complaint, Counterclaim by Silvergate Pharmaceuticals, Inc..(Dellinger, Megan)
Jan 4, 2021 40 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Bionpharma and Amneal's Preliminary Disclosure of Proposed Claim Terms and Constructions for U.S. Patent Nos. 10,772,868 B2 and 10,786,482 B2 filed by Bionpharma Inc..(Dorsney, Kenneth)
Dec 30, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (37 in 1:20-cv-01256-LPS, 35 in 1:20-cv-01255-LPS) STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to December 29, 2020 filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 12/30/20. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Dec 29, 2020 38 Proposed Order (18)
Docket Text: PROPOSED ORDER [Proposed] Scheduling Order by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Letter to The Honorable Leonard P. Stark)(Dellinger, Megan)
Dec 29, 2020 38 Letter to The Honorable Leonard P. Stark (2)
Dec 23, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (36 in 1:20-cv-01256-LPS, 34 in 1:20-cv-01255-LPS) STIPULATION TO EXTEND TIME to submit a Proposed Scheduling Order to December 23, 2020 filed by Silvergate Pharmaceuticals, Inc., (33 in 1:20-cv-01255-LPS, 35 in 1:20-cv-01256-LPS) STIPULATION TO EXTEND TIME to submit a Proposed Scheduling Order to December 22, 2020 filed by Silvergate Pharmaceuticals, Inc. Signed by Judge Leonard P. Stark on 12/23/20. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Dec 23, 2020 36 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Scheduling Order to December 23, 2020 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 23, 2020 37 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to December 29, 2020 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 18, 2020 35 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Scheduling Order to December 22, 2020 - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 17, 2020 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Andrew M. Alul, Richard T. Ruzich, Roshan P. Shrestha for Bionpharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Dec 14, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [34] MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul, Attorney Richard T. Ruzich and Attorney Roshan P. Shrestha filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 12/14/20. (ntl)
Dec 14, 2020 32 Answer to Amended Complaint (29)
Docket Text: ANSWER to Amended Complaint, re: [7] Amended Complaint , COUNTERCLAIM against All Plaintiffs by Bionpharma Inc..(Dorsney, Kenneth)
Dec 14, 2020 33 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bionpharma Inc.. (Dorsney, Kenneth)
Dec 14, 2020 34 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul, Attorney Richard T. Ruzich and Attorney Roshan P. Shrestha - filed by Bionpharma Inc.. (Dorsney, Kenneth)
Dec 11, 2020 31 Transcript (64)
Docket Text: Official Transcript of Telephone Conference held on December 1, 2020 before Chief Judge Leonard P. Stark. Court Reporter Jennifer Guy, email: jenniferguyrpr@gmail.com. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/4/2021. Redacted Transcript Deadline set for 1/11/2021. Release of Transcript Restriction set for 3/11/2021.(bpg)
Dec 10, 2020 30 Order (3)
Docket Text: ORDER regarding the Court's rulings on pending motions made during the 12/1/20 status conference. Proposed scheduling order due 12/18/20. Signed by Judge Leonard P. Stark on 12/8/20. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Dec 3, 2020 28 Status Report (5)
Docket Text: Joint STATUS REPORT by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 3, 2020 29 Proposed Order (3)
Docket Text: PROPOSED ORDER re Telephone Conference, by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Dec 1, 2020 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 12/1/2020. (Court Reporter: Jen Gray) Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-00678-LPS, 1:19-cv-01067-LPS, 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Nov 24, 2020 27 Redacted Document (30)
Docket Text: REDACTED VERSION of [22] Letter to The Honorable Leonard P. Stark from Kenneth L. Dorsney regarding Bionpharma's recent filings by Bionpharma Inc.. (Dorsney, Kenneth)
Nov 23, 2020 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a status teleconference is scheduled for December 1, 2020 at 11:15 a.m. The parties can access the teleconference by dialing 877-336-1829 and using the access code 1408971. ORDERED by Judge Leonard P. Stark on 11/23/2020. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-00678-LPS, 1:19-cv-01067-LPS, 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Nov 12, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [21] STIPULATION to File Confidential Documents Under Seal filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 11/12/20. (ntl)
Nov 12, 2020 25 Redacted Document (14)
Docket Text: REDACTED VERSION of (137 in 1:19-cv-01067-LPS) Reply Brief, (150 in 1:18-cv-01962-LPS) Reply Brief, (19 in 1:20-cv-01256-LPS) Reply Brief by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Nov 11, 2020 24 Letter (2)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Bionpharma's motions - re (140 in 1:19-cv-01067-LPS) MOTION for Leave to File Opposition to Amneal's Cross-Motion to Consolidate, (136 in 1:19-cv-01067-LPS, 149 in 1:18-cv-01962-LPS) MOTION for a Separate Trial under Fed. R. Civ. P. 42(b) , (22 in 1:20-cv-01256-LPS) Letter, (153 in 1:18-cv-01962-LPS) MOTION for Leave to File Opposition to Amneal's Cross-Motion to Consolidate. (Dellinger, Megan)
Nov 9, 2020 23 Letter (2)
Docket Text: Letter to The Honorable Leonard P. Stark from Megan E. Dellinger regarding Pending Motions. (Dellinger, Megan)
Nov 6, 2020 20 Redacted Document (28)
Docket Text: REDACTED VERSION of (135 in 1:19-cv-01067-LPS) Brief (Combined Answering and Reply), (148 in 1:18-cv-01962-LPS) Brief (Combined Answering and Reply), (18 in 1:20-cv-01256-LPS) Brief (Combined Answering and Reply), by Bionpharma Inc.. (Dorsney, Kenneth)
Nov 6, 2020 21 Stipulation (2)
Docket Text: STIPULATION File Confidential Documents Under Seal by Bionpharma Inc.. (Dorsney, Kenneth)
Oct 30, 2020 17 Letter (1)
Docket Text: Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Cross-Motion to Consolidate - re (118 in 1:19-cv-00678-LPS, 15 in 1:20-cv-01255-LPS) Cross MOTION to Consolidate Cases . (Attachments: # (1) Attachment 1, # (2) Attachment 2)(Gaza, Anne)
Oct 30, 2020 17 Attachment 1 (5)
Oct 30, 2020 17 Attachment 2 (56)
Oct 26, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (144 in 1:18-cv-01962-LPS, 15 in 1:20-cv-01256-LPS, 132 in 1:19-cv-01067-LPS) STIPULATION to Extend the Briefing Schedule regarding the Motion to Dismiss and Cross-Motion to Consolidate and to Change Page Limits filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 10/23/20. Associated Cases: 1:18-cv-01962-LPS, 1:19-cv-01067-LPS, 1:20-cv-01256-LPS (ntl)
Oct 26, 2020 16 Redacted Document (24)
Docket Text: REDACTED VERSION of (131 in 1:19-cv-01067-LPS) Brief (Combined Opening and Answering), (143 in 1:18-cv-01962-LPS) Brief (Combined Opening and Answering), (14 in 1:20-cv-01256-LPS) Brief (Combined Opening and Answering), by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Dellinger, Megan)
Oct 26, 2020 16 Exhibit A (2)
Oct 19, 2020 15 Stipulation (2)
Docket Text: STIPULATION to Extend the Briefing Schedule regarding the Motion to Dismiss and Cross-Motion to Consolidate and to Change Page Limits by Bionpharma Inc.. (Dorsney, Kenneth)
Oct 16, 2020 13 Motion to Consolidate Cases (4)
Docket Text: Cross MOTION to Consolidate Cases - filed by Silvergate Pharmaceuticals, Inc.. (Dellinger, Megan)
Oct 9, 2020 12 Redacted Document (21)
Docket Text: REDACTED VERSION of [10] Opening Brief in Support, of Motion to Dismiss Pursuant to Fed. R. Civ. P. 12(b)(6) and 12(b)(1) by Bionpharma Inc.. (Dorsney, Kenneth)
Oct 6, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] MOTION to Seal Document: [10] Opening Brief in Support of Motion to Dismiss filed by Bionpharma Inc. Signed by Judge Leonard P. Stark on 10/5/20. (ntl)
Oct 5, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Corrected document added to D.I. 11 per request of counsel. (ntl)
Oct 2, 2020 9 Motion for Miscellaneous Relief (2)
Docket Text: MOTION to Dismiss First Amended Complaint pursuant to Fed. R. Civ. P. 12(b)(6) and 12(b)(1) - filed by Bionpharma Inc.. (Dorsney, Kenneth)
Oct 2, 2020 11 Motion to Seal Document (2)
Docket Text: MOTION to Seal Document: [10] Opening Brief in Support, of Motion to Dismiss - filed by Bionpharma Inc.. (Dorsney, Kenneth) (Main Document 11 replaced on 10/5/2020) (ntl).
Sep 30, 2020 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: Removed the patent report from [7] Amended Complaint per request of counsel. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (ntl)
Sep 30, 2020 8 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,772,868 B2 ;10,786,482 B2 (Amended). (Dellinger, Megan)
Sep 29, 2020 7 Amended Complaint (8)
Docket Text: AMENDED COMPLAINT against Bionpharma Inc.- filed by Silvergate Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B (Dellinger, Megan) Modified on 9/30/2020 (ntl).
Sep 29, 2020 7 Exhibit A (29)
Sep 29, 2020 7 Exhibit B (28)
Sep 23, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:20-cv-01255-LPS, 1:20-cv-01256-LPS (rjb)
Sep 21, 2020 6 Summons Issued - Electronic (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr)
Sep 18, 2020 1 Exhibit A (29)
Sep 18, 2020 1 Civil Cover Sheet (1)
Sep 18, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Sep 18, 2020 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not Applicable. Date of Expiration of Patent: March 25, 2036.Thirty Month Stay Deadline: 4/30/2021*. * This is the deadline from C.A. No. 18-1962.(myr)
Sep 18, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,772,868 B2. (myr)
Sep 18, 2020 5 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Azurity Pharmaceuticals, Inc. for Silvergate Pharmaceuticals, Inc. filed by Silvergate Pharmaceuticals, Inc. (myr)
Sep 18, 2020 1 Complaint* (1)
Menu